These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14678970)

  • 1. Mismatch repair-dependent transcriptome changes in human cells treated with the methylating agent N-methyl-n'-nitro-N-nitrosoguanidine.
    di Pietro M; Marra G; Cejka P; Stojic L; Menigatti M; Cattaruzza MS; Jiricny J
    Cancer Res; 2003 Dec; 63(23):8158-66. PubMed ID: 14678970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLH1.
    Cejka P; Stojic L; Mojas N; Russell AM; Heinimann K; Cannavó E; di Pietro M; Marra G; Jiricny J
    EMBO J; 2003 May; 22(9):2245-54. PubMed ID: 12727890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase.
    Stojic L; Mojas N; Cejka P; Di Pietro M; Ferrari S; Marra G; Jiricny J
    Genes Dev; 2004 Jun; 18(11):1331-44. PubMed ID: 15175264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair and p53 independently affect sensitivity to N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea.
    Aquilina G; Ceccotti S; Martinelli S; Soddu S; Crescenzi M; Branch P; Karran P; Bignami M
    Clin Cancer Res; 2000 Feb; 6(2):671-80. PubMed ID: 10690553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homologous recombination rescues mismatch-repair-dependent cytotoxicity of S(N)1-type methylating agents in S. cerevisiae.
    Cejka P; Mojas N; Gillet L; Schär P; Jiricny J
    Curr Biol; 2005 Aug; 15(15):1395-400. PubMed ID: 16085492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
    Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
    Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells.
    Yan T; Berry SE; Desai AB; Kinsella TJ
    Clin Cancer Res; 2003 Jun; 9(6):2327-34. PubMed ID: 12796402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signalling cell cycle arrest and cell death through the MMR System.
    O'Brien V; Brown R
    Carcinogenesis; 2006 Apr; 27(4):682-92. PubMed ID: 16332722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells.
    Papouli E; Cejka P; Jiricny J
    Cancer Res; 2004 May; 64(10):3391-4. PubMed ID: 15150090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.
    Moreland NJ; Illand M; Kim YT; Paul J; Brown R
    Cancer Res; 1999 May; 59(9):2102-6. PubMed ID: 10232595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA mismatch repair-dependent activation of c-Abl/p73alpha/GADD45alpha-mediated apoptosis.
    Li LS; Morales JC; Hwang A; Wagner MW; Boothman DA
    J Biol Chem; 2008 Aug; 283(31):21394-403. PubMed ID: 18480060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
    Yeh CC; Lee C; Dahiya R
    Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.
    Cortellino S; Turner D; Masciullo V; Schepis F; Albino D; Daniel R; Skalka AM; Meropol NJ; Alberti C; Larue L; Bellacosa A
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15071-6. PubMed ID: 14614141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.
    Vikhanskaya F; Colella G; Valenti M; Parodi S; D'Incalci M; Broggini M
    Clin Cancer Res; 1999 Apr; 5(4):937-41. PubMed ID: 10213232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of eukaryotic expression plasmid DNA methyltransferase gene on methylation status and transcription level of DNA mismatch repair genes in human colon cancer cell line].
    Lu R; Fang JY; Zhu HY; Chen YX; Cheng ZH; Li EL
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1014-7. PubMed ID: 15312538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMR/c-Abl-dependent activation of ING2/p73alpha signaling regulates the cell death response to N-methyl-N'-nitro-N-nitrosoguanidine.
    Sun G; Jin S; Baskaran R
    Exp Cell Res; 2009 Nov; 315(18):3163-75. PubMed ID: 19766113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors.
    Olasz J; Mándoky L; Géczi L; Bodrogi I; Csuka O; Bak M
    Anticancer Res; 2005; 25(6B):4319-24. PubMed ID: 16309235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
    Arnold CN; Goel A; Boland CR
    Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.